我武生物
(300357)
| 流通市值：106.98亿 | | | 总市值：115.71亿 |
| 流通股本：4.84亿 | | | 总股本：5.24亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,195,259,993.17 | 1,171,377,407.31 | 1,067,376,344.39 | 1,182,357,704.21 |
| 应收票据及应收账款 | 188,033,525.9 | 161,583,153.69 | 276,218,527.44 | 218,214,214.73 |
| 其中：应收票据 | 11,776,703.84 | 18,620,344.02 | 55,761,204.45 | 52,291,194.67 |
| 应收账款 | 176,256,822.06 | 142,962,809.67 | 220,457,322.99 | 165,923,020.06 |
| 应收款项融资 | 39,165,729.23 | 41,337,947.58 | - | - |
| 预付款项 | 5,343,686.62 | 5,819,065.18 | 11,411,051.7 | 11,875,343.88 |
| 其他应收款合计 | 7,200,985.39 | 6,196,880.15 | 21,470,003.02 | 20,595,118.64 |
| 存货 | 60,086,525.6 | 59,037,504.11 | 55,390,121.92 | 53,143,166.41 |
| 其他流动资产 | 12,776,532.04 | 7,155,301.43 | 15,718,075.63 | 11,779,842.5 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,595,653,977.74 | 1,569,894,078.45 | 1,564,064,911.55 | 1,589,807,108.35 |
| 非流动资产: | | | | |
| 长期股权投资 | 73,723,183.13 | 74,213,191.37 | 74,598,199.52 | 76,456,442.94 |
| 其他权益工具投资 | 5,403,206.52 | - | - | - |
| 投资性房地产 | - | - | 10,816,759.44 | - |
| 固定资产 | 449,379,790.06 | 448,616,840.96 | 420,405,918.14 | 196,592,919.62 |
| 在建工程 | 261,765,009.8 | 227,855,260.19 | 215,332,897.89 | 360,203,283.39 |
| 使用权资产 | 26,805,466.47 | 28,368,795.1 | 23,304,816.87 | 17,993,572.87 |
| 无形资产 | 158,171,747.36 | 161,382,462.31 | 164,517,334 | 167,559,789.97 |
| 开发支出 | 28,103,170.57 | 27,037,442.44 | 24,511,960.68 | 20,692,280.85 |
| 长期待摊费用 | 6,894,846.19 | 7,340,894.48 | 7,030,993.12 | 5,925,360.75 |
| 递延所得税资产 | 5,233,202.47 | 5,034,520.57 | 6,073,996.97 | 5,452,130.32 |
| 其他非流动资产 | 13,006,770 | 12,423,230 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,028,486,392.57 | 992,272,637.42 | 946,592,876.63 | 850,875,780.71 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,624,140,370.31 | 2,562,166,715.87 | 2,510,657,788.18 | 2,440,682,889.06 |
| 流动负债: | | | | |
| 短期借款 | 49,173,249.53 | 34,391,759.19 | 14,666,530.2 | 27,333,265.1 |
| 应付票据及应付账款 | 7,489,563.16 | 7,991,954.63 | 7,729,846.63 | 6,461,524.88 |
| 应付账款 | 7,489,563.16 | 7,991,954.63 | 7,729,846.63 | 6,461,524.88 |
| 合同负债 | 1,497,008.29 | 384,279.44 | 226,277.71 | 336,457.47 |
| 应付职工薪酬 | 19,752,004.99 | 29,035,505.84 | 25,672,646.6 | 19,021,267.99 |
| 应交税费 | 19,033,368.89 | 14,502,342.06 | 29,777,551.52 | 18,703,589.58 |
| 其他应付款合计 | 57,764,951.11 | 83,939,171.54 | 82,430,293.94 | 141,614,394.51 |
| 应付股利 | - | - | - | 104,716,800 |
| 一年内到期的非流动负债 | 7,206,732.62 | 6,795,183.91 | 7,525,601.32 | 4,818,612.21 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 161,916,878.59 | 177,040,196.61 | 168,028,747.92 | 218,289,111.74 |
| 非流动负债: | | | | |
| 租赁负债 | 19,528,597.03 | 21,256,115.9 | 14,970,868.83 | 12,609,072.66 |
| 递延收益 | 30,493,326.07 | 30,931,569.13 | 31,306,786.99 | 31,590,600.85 |
| 递延所得税负债 | 202,253.94 | 203,236.78 | 248,961.86 | 159,463.79 |
| 其他非流动负债 | 29,029,182.86 | 29,029,182.86 | 28,218,783.21 | 28,218,783.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 79,253,359.9 | 81,420,104.67 | 74,745,400.89 | 72,577,920.51 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 241,170,238.49 | 258,460,301.28 | 242,774,148.81 | 290,867,032.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 523,584,000 | 523,584,000 | 523,584,000 | 523,584,000 |
| 资本公积 | 128,194,388.22 | 128,194,388.22 | 128,194,388.22 | 128,194,388.22 |
| 其他综合收益 | 5,378,683.48 | 30,850.8 | 34,641.98 | 36,091.56 |
| 盈余公积 | 270,715,165.14 | 270,715,165.14 | 235,115,138.58 | 235,115,138.58 |
| 未分配利润 | 1,339,782,370.99 | 1,262,575,050.26 | 1,258,051,727.64 | 1,136,508,428.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,267,654,607.83 | 2,185,099,454.42 | 2,144,979,896.42 | 2,023,438,047.15 |
| 少数股东权益 | 115,315,523.99 | 118,606,960.17 | 122,903,742.95 | 126,377,809.66 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,382,970,131.82 | 2,303,706,414.59 | 2,267,883,639.37 | 2,149,815,856.81 |
| 负债和股东权益合计 | 2,624,140,370.31 | 2,562,166,715.87 | 2,510,657,788.18 | 2,440,682,889.06 |
| 公告日期 | 2024-04-19 | 2024-04-19 | 2023-10-26 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |